No abstract available
MeSH terms
-
Aged
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use*
-
Benzamides / therapeutic use*
-
Humans
-
Imatinib Mesylate
-
Leukemia, Lymphocytic, Chronic, B-Cell / complications
-
Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
-
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Leukocyte Count
-
Leukocytosis / complications
-
Leukocytosis / diagnosis*
-
Leukocytosis / drug therapy
-
Leukocytosis / pathology
-
Male
-
Piperazines / therapeutic use*
-
Pyrimidines / therapeutic use*
-
Remission Induction
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate